Sold Out
Book Categories |
Contributing Authors | ||
Preface | ||
Sect. I | General Principles | 1 |
1 | Principles of Antiepileptic Drug Action | 3 |
2 | Neurophysiological Effects of Antiepileptic Drugs | 23 |
3 | Discovery and Preclinical Development of Antiepileptic Drugs | 36 |
4 | New Antiepileptic Drug Development: Medical Perspective | 49 |
5 | Clinical Development of Antiepileptic Drugs: Industry Perspective | 58 |
6 | The Development of Antiepilepsy Drugs: Regulatory Perspective | 66 |
7 | Antiepileptic Drug Monotherapy in Adults: Selection and Use in New-Onset Epilepsy | 72 |
8 | Combination Therapy and Drug Interactions | 96 |
9 | Laboratory Monitoring of Antiepileptic Drugs | 103 |
10 | Safety Monitoring of Antiepileptic Drugs | 112 |
11 | Use of Antiepileptic Drugs in Children | 119 |
12 | Antiepileptic Drug Use in Women | 132 |
13 | Epilepsy in the Elderly | 149 |
14 | Treatment of Status Epilepticus | 159 |
15 | Prevention of Epileptogenesis | 169 |
Sect. II | Benzodiazepines | 177 |
16 | Mechanisms of Action | 179 |
17 | Chemistry, Biotransformation, and Pharmacokinetics | 187 |
18 | Clinical Efficacy and Use in Epilepsy | 206 |
19 | Adverse Effects | 215 |
Sect. III | Carbamazepine | 225 |
20 | Mechanisms of Action | 227 |
21 | Chemistry, Biotransformation, and Pharmacokinetics | 236 |
22 | Interactions with Other Drugs | 247 |
23 | Clinical Efficacy and Use in Epilepsy | 262 |
24 | Clinical Efficacy and Use in Other Neurological Disorders | 273 |
25 | Clinical Efficacy and Use in Psychiatric Disorders | 278 |
26 | Adverse Effects | 285 |
Sect. IV | Felbamate | 299 |
27 | Felbamate | 301 |
Sect. V | Gabapentin | 319 |
28 | Mechanisms of Action | 321 |
29 | Chemistry, Biotransformation, Pharmacokinetics, and Interactions | 335 |
30 | Clinical Use | 340 |
31 | Clinical Efficacy and Use in Other Neurological Disorders | 344 |
32 | Clinical Efficacy and Use in Psychiatric Disorders | 349 |
33 | Adverse Effects | 354 |
Sect. VI | Lamotrigine | 361 |
34 | Mechanisms of Action | 363 |
35 | Chemistry, Biotransformation, and Pharmacokinetics | 370 |
36 | Interactions with Other Drugs | 380 |
37 | Clinical Efficacy and Use in Epilepsy | 389 |
38 | Efficacy and Use in Nonepileptic Disorders | 403 |
39 | Adverse Effects | 408 |
Sect. VII | Levetiracetam | 417 |
40 | Mechanisms of Action | 419 |
41 | Chemistry, Biotransformation, Pharmacokinetics, and Drug Interactions | 428 |
42 | Clinical Use | 433 |
43 | Adverse Experiences | 442 |
Sect. VIII | Oxcarbazepine | 449 |
44 | Mechanisms of Action | 451 |
45 | Chemistry, Biotransformation, and Pharmacokinetics | 459 |
46 | Interactions with Other Drugs | 466 |
47 | Clinical Efficacy and Use in Epilepsy | 470 |
48 | Clinical Efficacy and Use in Psychiatric Disorders | 476 |
49 | Adverse Effects | 479 |
Sect. IX | Phenobarbital and Other Barbiturates | 487 |
50 | Mechanisms of Action | 489 |
51 | Chemistry, Biotransformation, and Pharmacokinetics | 496 |
52 | Interactions with Other Drugs | 504 |
53 | Clinical Efficacy and Use in Epilepsy | 514 |
54 | Clinical Efficacy and Use in Nonepileptic Disorders | 522 |
55 | Adverse Effects | 528 |
56 | Methylphenobarbital | 541 |
Sect. X | Phenytoin and Other Hydantoins | 549 |
57 | Mechanisms of Action | 551 |
58 | Chemistry and Biotransformation | 565 |
59 | Interactions with Other Drugs | 581 |
60 | Clinical Efficacy and Use in Epilepsy | 591 |
61 | Clinical Efficacy and Use in Other Neurological Disorders | 597 |
62 | Clinical Efficacy and Use in Psychiatric Disorders | 600 |
63 | Adverse Effects | 605 |
64 | Fosphenytoin | 611 |
Sect. XI | Primidone | 619 |
65 | Primidone | 621 |
Sect. XII | Succinimides | 637 |
66 | Mechanisms of Action | 639 |
67 | Ethosuximide: Chemistry, Biotransformation, Pharmacokinetics, and Drug Interactions | 646 |
68 | Clinical Efficacy and Use in Epilepsy | 652 |
69 | Adverse Effects | 658 |
70 | Methsuximide | 665 |
Sect. XIII | Tiagabine | 673 |
71 | Mechanisms of Action | 675 |
72 | Chemistry, Biotransformation, and Pharmacokinetics | 681 |
73 | Drug Interactions | 691 |
74 | Clinical Efficacy and Use in Epilepsy | 698 |
75 | Clinical Efficacy and Use in Nonepileptic Disorders | 705 |
76 | Adverse Effects | 711 |
Sect. XIV | Topiramate | 717 |
77 | Mechanisms of Action | 719 |
78 | Chemistry, Biotransformation, and Pharmacokinetics | 727 |
79 | Drug Interactions | 735 |
80 | Clinical Efficacy and Use in Epilepsy | 740 |
81 | Clinical Efficacy and Use in Nonepileptic Disorders | 753 |
82 | Adverse Effects | 760 |
Sect. XV | Valproic Acid | 765 |
83 | Mechanisms of Action | 767 |
84 | Chemistry, Biotransformation, and Pharmacokinetics | 780 |
85 | Drug Interactions | 801 |
86 | Clinical Efficacy and Use in Epilepsy | 808 |
87 | Clinical Efficacy and Use in Other Neurological Disorders | 818 |
88 | Clinical Efficacy and Use in Psychiatric Disorders | 828 |
89 | Adverse Effects | 837 |
Sect. XVI | Vigabatrin | 853 |
90 | Vigabatrin | 855 |
Sect. XVII | Zonisamide | 865 |
91 | Mechanisms of Action | 867 |
92 | Chemistry, Biotransformation, and Pharmacokinetics | 873 |
93 | Drug Interactions | 880 |
94 | Clinical Efficacy and Use in Epilepsy | 885 |
95 | Adverse Effects | 892 |
Sect. XVIII | Drugs in Development | 899 |
96 | Pregabalin | 901 |
97 | Rufinamide | 906 |
98 | Drugs in Early Clinical Development | 913 |
Subject Index | 929 |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionAntiepileptic Drugs
X
This Item is in Your InventoryAntiepileptic Drugs
X
You must be logged in to review the productsX
X
X
Add Antiepileptic Drugs, , Antiepileptic Drugs to the inventory that you are selling on WonderClubX
X
Add Antiepileptic Drugs, , Antiepileptic Drugs to your collection on WonderClub |